Articoli di riviste sul tema "XP"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Vedi i top-50 articoli di riviste per l'attività di ricerca sul tema "XP".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.
Cowham, R. "To XP or not to XP?" ITNOW 47, no. 2 (2005): 16. http://dx.doi.org/10.1093/itnow/bwi030.
Testo completoFischer, R., M. Uhl, and H. Vonach. "Nb93(n,xp),Agnat(n,xp), andInnat(n,xp) reactions at 14.1 MeV." Physical Review C 37, no. 2 (1988): 578–86. http://dx.doi.org/10.1103/physrevc.37.578.
Testo completoSonia, Archana Singhal, and Hema Banati. "FISA-XP." ACM SIGSOFT Software Engineering Notes 39, no. 3 (2014): 1–14. http://dx.doi.org/10.1145/2597716.2597728.
Testo completoLitts, Thom, and Jeff Kopaska. "RIP XP." Fisheries 39, no. 4 (2014): 151. http://dx.doi.org/10.1080/03632415.2014.893871.
Testo completoIvorra, Wilfrid. "Sur les équations xp+2βyp= z2et xp+2βyp= 2z2". Acta Arithmetica 108, № 4 (2003): 327–38. http://dx.doi.org/10.4064/aa108-4-3.
Testo completoLee, Jeeyun, Do Hoon Lim, Sung Kim, et al. "Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial." Journal of Clinical Oncology 30, no. 3 (2012): 268–73. http://dx.doi.org/10.1200/jco.2011.39.1953.
Testo completoFassihi, Hiva, Mieran Sethi, Heather Fawcett, et al. "Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect." Proceedings of the National Academy of Sciences 113, no. 9 (2016): E1236—E1245. http://dx.doi.org/10.1073/pnas.1519444113.
Testo completoAbid, Kalthoum, Jihene Bettaieb, Faouzi El Mezni, and Hamouda Boussen. "Proinflammatory cytokines in xeroderma pigmentosum (XP) and non-XP cancer patients—a pilot study." Exploration of Immunology 4, no. 4 (2024): 557–67. http://dx.doi.org/10.37349/ei.2024.00159.
Testo completoMaxmen, Amy. "XP mutant power!" Journal of Experimental Medicine 206, no. 13 (2009): 2856. http://dx.doi.org/10.1084/jem.20613iti2.
Testo completoMoreira, Danilo José Silva, Juliana Brito da Fonseca, Karoline Rossi та ін. "Общие аспекты пигментной ксеродермии: обзор". Núcleo do Conhecimento 11, № 03 (2020): 114–26. https://doi.org/10.32749/nucleodoconhecimento.com.br/ru/70626.
Testo completoKunwar, Sundar. "Enabling and Limiting factors in eXtreme Programming (XP) with Evaluation Framework." SCITECH Nepal 14, no. 1 (2019): 50–62. http://dx.doi.org/10.3126/scitech.v14i1.25534.
Testo completoRapićOtrin, Vesna, Isao Kuraoka, Tiziana Nardo, et al. "Relationship of the Xeroderma Pigmentosum Group E DNA Repair Defect to the Chromatin and DNA Binding Proteins UV-DDB and Replication Protein A." Molecular and Cellular Biology 18, no. 6 (1998): 3182–90. http://dx.doi.org/10.1128/mcb.18.6.3182.
Testo completoMoreira, Danilo José Silva, Juliana Brito da Fonseca, Karoline Rossi, et al. "Allgemeine Aspekte von Xeroderma pigmentosum: Eine Übersicht." Núcleo do Conhecimento 11, no. 03 (2020): 114–26. https://doi.org/10.32749/nucleodoconhecimento.com.br/gesundheit/aspekte-von-xeroderma.
Testo completoStanojevic, Jelena. "On estimation of high quantiles for certain classes of distributions." Yugoslav Journal of Operations Research 25, no. 2 (2015): 299–312. http://dx.doi.org/10.2298/yjor130606013s.
Testo completoMoreira, Danilo José Silva, Juliana Brito da Fonseca, Karoline Rossi, et al. "Aspectos gerais do xeroderma pigmentoso: Uma revisão." Núcleo do Conhecimento 11, no. 03 (2020): 114–26. https://doi.org/10.32749/nucleodoconhecimento.com.br/saude/aspectos-gerais-do-xeroderma.
Testo completoMoreira, Danilo José Silva, Juliana Brito da Fonseca, Karoline Rossi, et al. "Aspetti generali dello xeroderma pigmentoso: una revisione." Núcleo do Conhecimento 11, no. 03 (2022): 114–26. https://doi.org/10.32749/nucleodoconhecimento.com.br/salute/generali-dello-xeroderma.
Testo completoMoreira, Danilo José Silva, Juliana Brito da Fonseca, Karoline Rossi, et al. "General aspects of xeroderma pigmentosum: A review." Núcleo do Conhecimento 11, no. 03 (2020): 114–26. https://doi.org/10.32749/nucleodoconhecimento.com.br/health/xeroderma-pigmentosum.
Testo completoKim, Jinsu, and Wonho Lee. "Flood Inundation Analysis in Urban Area Using XP-SWMM." Journal of the Korean Geoenvironmental Society 16, no. 1 (2015): 29–36. http://dx.doi.org/10.14481/jkges.2015.16.1.29.
Testo completoSuman, AHM Khairul Imam, Khadija Begum, Kaniz Rahman, et al. "Association of Xanthelasma palpebrarum (XP) with cardiovascular disease (CVD) risk factors." Asian Journal of Medical and Biological Research 5, no. 4 (2020): 324–29. http://dx.doi.org/10.3329/ajmbr.v5i4.45271.
Testo completoMoreira, Danilo José Silva, Juliana Brito da Fonseca, Karoline Rossi, et al. "Aspectos generales del xeroderma pigmentoso: una revisión." Núcleo do Conhecimento 11, no. 03 (2020): 114–26. https://doi.org/10.32749/nucleodoconhecimento.com.br/salud/xeroderma-pigmentoso.
Testo completoVaz-Garcia, Eduarda Santiago, Victor Talarico Leal Vieira, Natasha Pereira da Silva Ferreira Petitet, et al. "Mechanical Properties of Anatomic Finishing Files: XP-Endo Finisher and XP-Clean." Brazilian Dental Journal 29, no. 2 (2018): 208–13. http://dx.doi.org/10.1590/0103-6440201801903.
Testo completoGambichler, Thilo, Julia Hyun, Frank Oellig, Jürgen C. Becker, and Alexander Kreuter. "Immuncheckpoint‐Inhibitoren bei Kindern mit Xeroderma pigmentosum und fortgeschrittenem kutanen Plattenepithelkarzinom: Fallvorstellung und kurzer Überblick." JDDG: Journal der Deutschen Dermatologischen Gesellschaft 23, no. 3 (2025): 303–10. https://doi.org/10.1111/ddg.15648_g.
Testo completoWebster, Mark A., Benjamin J. Brown, and Stephen D. Bartlett. "The XP Stabiliser Formalism: a Generalisation of the Pauli Stabiliser Formalism with Arbitrary Phases." Quantum 6 (September 22, 2022): 815. http://dx.doi.org/10.22331/q-2022-09-22-815.
Testo completoKim, Young Geun, Jae Wook Oh, Keun Cheol Lee, and Sung Ho Yoon. "Clinical association between serum cholesterol level and the size of xanthelasma palpebrarum." Archives of Craniofacial Surgery 23, no. 2 (2022): 71–76. http://dx.doi.org/10.7181/acfs.2022.00185.
Testo completoPhillies, George David Joseph. "Simulational Tests of the Rouse Model." Polymers 15, no. 12 (2023): 2615. http://dx.doi.org/10.3390/polym15122615.
Testo completoPrice, Vera H. "Trichothiodystrophy: Current Concepts." Journal of Cutaneous Medicine and Surgery 1, no. 1 (1996): 45–49. http://dx.doi.org/10.1177/120347549600100113.
Testo completoMiao, Junjie, Changchun Chai, Wei Zhang, Yanxing Song, and Yintang Yang. "First-Principles Study on Structural, Mechanical, Anisotropic, Electronic and Thermal Properties of III-Phosphides: XP (X = Al, Ga, or In) in the P6422 Phase." Materials 13, no. 3 (2020): 686. http://dx.doi.org/10.3390/ma13030686.
Testo completoLee, J., W. Kang, D. Lim, et al. "Phase III trial of adjuvant capecitabine/cisplatin (XP) versus capecitabine/cisplatin/RT (XPRT) in resected gastric cancer with D2 nodal dissection (ARTIST trial): Safety analysis." Journal of Clinical Oncology 27, no. 15_suppl (2009): 4537. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.4537.
Testo completoFernández-Sánchez, Javier. "Against a clausal ellipsis account of all stripping strings in Spanish." Poznan Studies in Contemporary Linguistics 55, no. 1 (2018): 53–87. http://dx.doi.org/10.1515/psicl-2019-0003.
Testo completoReifer, D. J. "XP and the CMM." IEEE Software 20, no. 3 (2003): 14–15. http://dx.doi.org/10.1109/ms.2003.1196314.
Testo completoTorre, Alberto C. de la. "The ubiquitous XP commutator." European Journal of Physics 27, no. 2 (2006): 225–30. http://dx.doi.org/10.1088/0143-0807/27/2/005.
Testo completoFraser, Steven, and Giancarlo Succi. "XP requirement negotiation workshop." ACM SIGAPP Applied Computing Review 10, no. 1 (2002): 26–31. http://dx.doi.org/10.1145/568235.568239.
Testo completoSchwarz, Diemo, and Etienne Brunet. "theconcatenator: Placard XP edit." Leonardo Music Journal 18 (December 2008): 89–90. http://dx.doi.org/10.1162/lmj.2008.18.89b.
Testo completoJ.-M.M. "XP Centaur en majesté." Revue Francophone des Laboratoires 2007, no. 388 (2007): 10. http://dx.doi.org/10.1016/s1773-035x(07)80003-7.
Testo completoGengler, Barbara. "XP a National Threat?" Network Security 2001, no. 11 (2001): 5. http://dx.doi.org/10.1016/s1353-4858(01)01111-4.
Testo completoSundar, Kunwar. "Extreme Programming (XP) Simplified." European Journal of Advances in Engineering and Technology 5, no. 3 (2018): 198–206. https://doi.org/10.5281/zenodo.10702437.
Testo completoBeroual, Nabil, and Ahmed Bendjeddou. "On a Predator–Prey System with Holling Functional Response: xp/(a + xp)." National Academy Science Letters 39, no. 1 (2015): 43–46. http://dx.doi.org/10.1007/s40009-015-0400-6.
Testo completoSarasin, Alain. "The French Cohort of DNA Repair-Deficient Xeroderma Pigmentosum Patients: Risk of Hematological Malignancies." Cancers 15, no. 10 (2023): 2706. http://dx.doi.org/10.3390/cancers15102706.
Testo completoMoreira, Danilo José Silva, Juliana Brito da Fonseca, Karoline Rossi, et al. "Aspects généraux de Xeroderma pigmentosum: un examen." Núcleo do Conhecimento 11, no. 03 (2020): 114–26. https://doi.org/10.32749/nucleodoconhecimento.com.br/sante/generaux-de-xeroderma.
Testo completoRana, MS, MM Rahman, UK Rima, and NS Juyena. "General anaesthesia of indigenous pigs in Bangladesh." Bangladesh Veterinarian 30, no. 2 (2014): 46–53. http://dx.doi.org/10.3329/bvet.v30i2.18254.
Testo completoKarentz, D., and J. E. Cleaver. "Repair-deficient xeroderma pigmentosum cells made UV light resistant by fusion with X-ray-inactivated Chinese hamster cells." Molecular and Cellular Biology 6, no. 10 (1986): 3428–32. http://dx.doi.org/10.1128/mcb.6.10.3428-3432.1986.
Testo completoKarentz, D., and J. E. Cleaver. "Repair-deficient xeroderma pigmentosum cells made UV light resistant by fusion with X-ray-inactivated Chinese hamster cells." Molecular and Cellular Biology 6, no. 10 (1986): 3428–32. http://dx.doi.org/10.1128/mcb.6.10.3428.
Testo completoMartens, M. C., L. Boeckmann, and S. Emmert. "Genetisch bedingte Hauterkrankungen – Xeroderma pigmentosum und das CEDNIK-Syndrom." Aktuelle Dermatologie 46, no. 08/09 (2020): 375–78. http://dx.doi.org/10.1055/a-1148-3867.
Testo completoHajar Tahiri, Fatima zahra El Fatoiki, Meriem Regragui, Fouzia. Hali, and Soumiya .Chiheb. "A rare occurrence of Hodgkin lymphoma in a Xeroderma pigmentosum patient: A case report and literature review." World Journal of Advanced Research and Reviews 22, no. 1 (2024): 1484–86. http://dx.doi.org/10.30574/wjarr.2024.22.1.1179.
Testo completoHajar, Tahiri, zahra El Fatoiki Fatima, Regragui Meriem, Hali Fouzia., and .Chiheb Soumiya. "A rare occurrence of Hodgkin lymphoma in a Xeroderma pigmentosum patient: A case report and literature review." World Journal of Advanced Research and Reviews 22, no. 1 (2024): 1484–86. https://doi.org/10.5281/zenodo.14225598.
Testo completoAlakshar, Asmaa, Abdul Rahman Mohammed Saleh, and Mehmet Omer Gorduysus. "Debris and Smear Layer Removal from Oval Root Canals Comparing XP-Endo Finisher, EndoActivator, and Manual Irrigation: A SEM Evaluation." European Journal of Dentistry 14, no. 04 (2020): 626–33. http://dx.doi.org/10.1055/s-0040-1714762.
Testo completoRothkopf, Michael. "An Algorithmic Approach for Lipid Metabolism and Management of Patients with Xanthelasma Palpebrarum (XP)." Current Developments in Nutrition 4, Supplement_2 (2020): 1140. http://dx.doi.org/10.1093/cdn/nzaa055_025.
Testo completoSugimoto, Naotoshi, Tetsuhiro Yoshinami, Sachiko Yamamoto, Toshinari Yagi, and Fumio Imamura. "Does capecitabine plus cisplatin (XP) give advanced or recurrent gastric cancer (AGC) patients higher early tumor shrinkage (ETS) rate than S1 plus cisplatin (SP) with safety?" Journal of Clinical Oncology 33, no. 3_suppl (2015): 172. http://dx.doi.org/10.1200/jco.2015.33.3_suppl.172.
Testo completoTakeno, Atsushi, Youichi Makari, Shunji Endo, et al. "Randomized, open-label, phase II study comparing five-weekly S-1 plus cisplatin (SP) with tri-weekly capecitabine plus cisplatin (XP) in chemotherapy-naïve patients with HER2 negative advanced gastric cancer (AGC): OGSG 1105 HERBIS-4A trial." Journal of Clinical Oncology 36, no. 4_suppl (2018): 102. http://dx.doi.org/10.1200/jco.2018.36.4_suppl.102.
Testo completoBahrudin, Ida Aryanie, Rafizah Mohd Hanifa, Mohd Ezree Abdullah, and Muhammad Firdaus Kamarudin. "Adapting eXtreme Programming Approach in Developing Electronic Document Online System (eDoc)." Applied Mechanics and Materials 321-324 (June 2013): 2938–41. http://dx.doi.org/10.4028/www.scientific.net/amm.321-324.2938.
Testo completo